Tara Santora is a former intern at Spectrum and a freelance journalist based in New York City. Tara has written about health and the environment for publications such as Psychology Today and Audubon magazine. They are also a graduate student at New York University’s Science, Health & Environmental Reporting Program.
Tara Santora
From this contributor
U.S. authorizes rapid blood test for fragile X syndrome
A new blood test can identify within seven hours whether a person carries the genetic mutation underlying fragile X syndrome.
U.S. authorizes rapid blood test for fragile X syndrome
New analysis of brain activity could identify signal for autism
A new technique allows researchers to analyze raw data across multiple studies that use electroencephalography.
New analysis of brain activity could identify signal for autism
Machine learning flags ‘mosaic’ mutations that may contribute to autism
A new technique detects rare mutations that occur in only a subset of the body's cells.
Machine learning flags ‘mosaic’ mutations that may contribute to autism
Smart jumpsuit may help test motor skills in infants with autism
A new jumpsuit is fitted with sensors that can track and classify an infant's posture and movements.
Smart jumpsuit may help test motor skills in infants with autism
Artificial neurons may repair damaged cells and circuits
Electronic neurons made from silicon mimic brain cells and could be used to treat conditions such as autism.
Artificial neurons may repair damaged cells and circuits
Explore more from The Transmitter
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Additional data suggest changes in diagnostics underlie increases in autism diagnoses, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 14 September.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
Building brain-computer interfaces at a neurotech company
At Blackrock Neurotech, Spencer Kellis develops implantable devices that help people with brain and spinal cord conditions communicate, move and more.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.
‘High risk, high reward’: How early-career neuroscientists view their future
The Transmitter and Neuromatch surveyed more than 300 early-career neuroscientists to better understand their unique challenges, career aspirations and support needs.